Latest news about Sattva Sukun Lifecare
Sattva Sukun Lifecare
1.12
+0.05(+4.67%)
Company Performance:
View Company Insights1D+4.67%
1M+51.35%
6M+55.56%
1Y+36.59%
5Y0.00%
More news about Sattva Sukun Lifecare
05Sept 26
Tavexia Lifecare adjourns board meeting from Sep 4 to Sep 7
Tavexia Lifecare adjourns board meeting from September 4 to September 7, 2026. Postponement due to unavoidable circumstances. Agenda items including FY26 results and AGM logistics remain unchanged. Re-appointment of independent director Khushboo Vasudev on agenda.
05Aug 26
Sattva Sukun Lifecare Q1 Results: Net Loss Widens To ₹23.38 Lakh, Revenue Falls 81%
Sattva Sukun Lifecare Ltd posted a Q1FY27 standalone net loss of ₹23.38 lakh, reversing a profit of ₹65.14 lakh in Q1FY26. Revenue collapsed 80.7% YoY to ₹23.41 lakh while expenses rose 15.9% to ₹60.77 lakh. Consolidated net loss was ₹16.01 lakh. The company filed results on August 5, 2026.
04Aug 26
Sattva Sukun Lifecare reports ₹22.35 lakh Q1FY26 loss on sales drop
Sattva Sukun Lifecare's Q1FY26 results reveal a sharp downturn with standalone net loss widening to ₹22.35 lakh against a prior-year profit of ₹65.14 lakh. Net sales collapsed by over 80% to ₹23.40 lakh, while expenses rose nearly 16%. The company also disclosed revised utilization plans for its July 2025 rights issue proceeds.
22Jul 26
Sattva Sukun Lifecare shareholders approve name change to Tavexia
Sattva Sukun Lifecare Limited held an Extra-Ordinary General Meeting on July 22, 2026, where shareholders approved the change of name to Tavexia Lifecare Limited and the alteration of the Memorandum of Association. The meeting also passed resolutions for the regularization of Mr. Sachin Bhanubhai Manseta as an Independent Director and Mr. Chirag Dedhia as a Non-Executive Director.
30Jun 26
Sattva Sukun Lifecare approves name change and EGM for July 22
Sattva Sukun Lifecare Limited's board approved the regularization of Mr. Sachin Bhanubhai Manseta and Mr. Chirag Dedhia as directors and proposed changing the company name to Tavexia Lifecare Limited. The board also approved altering the Memorandum of Association to expand business activities and shifting the registered office within Mumbai effective July 1, 2026. An Extra-Ordinary General Meeting is scheduled for July 22, 2026, to seek shareholder approval for these resolutions.
08Jun 26
Sattva Sukun submits audited FY26 results to BSE
Sattva Sukun Lifecare Limited submitted newspaper clippings of its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, to BSE. The company reported a net profit of ₹16.52 lakh for FY26, reversing from a loss in the prior quarter. Total income for the year decreased to ₹423.70 lakh, while expenses rose to ₹420.78 lakh.
24Apr 26
Sattva Sukun Lifecare Limited Appoints Two New Directors to Board
Sattva Sukun Lifecare Limited appointed Mr. Sachin Bhanubhai Manseta as Additional cum Non-Executive Independent Director and Mr. Chirag Dedhia as Additional cum Non-Executive Non-Independent Director effective April 24th, 2026. The appointments were approved during a board meeting held at the company's Mumbai office and comply with SEBI regulations, subject to member approval.
08Apr 26
Sattva Sukun Lifecare Limited Submits SEBI Compliance Certificate for Q4FY26
Sattva Sukun Lifecare Limited filed its quarterly SEBI compliance certificate for Q4FY26 with BSE Limited on 08/04/2026. The certificate, issued under Regulation 74(5) of SEBI Depositories Regulations, confirms proper handling of dematerialisation processes during the quarter ended 31st March, 2026. RTA Niche Technologies Pvt. Ltd. verified that all securities were properly processed and regulatory requirements were met.
11Mar 26
Roshan Dealmark Private Limited Disposes 44,000 Equity Shares in Sattva Sukun Lifecare Ltd
Roshan Dealmark Private Limited has disposed of 44,000 equity shares in Sattva Sukun Lifecare Ltd through an on-market transaction, reducing the promoter group's stake from 6.41% to 6.39%. The transaction was executed on March 10, 2026, and disclosed in compliance with SEBI regulations governing substantial acquisitions and insider trading.
15Feb 26
Sattva Sukun Lifecare Board Meeting Adjourned Due to Lack of Quorum, Q3FY26 Results Delayed
Sattva Sukun Lifecare Limited's board meeting scheduled for February 14, 2026, to approve Q3FY26 unaudited financial results was adjourned due to insufficient quorum. The company has informed BSE about the delay and rescheduled the meeting for February 16, 2026, maintaining commitment to regulatory compliance.
05Dec 25
Sattva Sukun Lifecare Delays Q2 Results Due to Subsidiary Acquisition
Sattva Sukun Lifecare Limited has postponed filing its financial results for Q2 and H1 ending September 30, 2025, due to the recent acquisition of Pavapuri Export Private Limited. The delay is attributed to the need for preparing consolidated financial statements, aligning accounting policies, and finalizing consolidated accounts. The company has rescheduled its board meeting to November 25, 2025, for approving the financial results. Sattva Sukun Lifecare has informed the BSE Limited that the delay was unintentional and caused by procedural requirements related to the acquisition.
25Nov 25
Sattva Sukun Lifecare Reports Strong Q2 FY2026 Performance and Completes Rights Issue
Sattva Sukun Lifecare Limited (SSLL) reported net sales of Rs 195.98 lakhs and a profit of Rs 60.40 lakhs for Q2 FY2026. The company successfully completed a rights issue of 19.16 crore equity shares, raising Rs 1,916 lakhs. The funds are allocated for strategic investment in subsidiary PavaPuri Export Private Limited (Rs 1,000 lakhs), business expansion (Rs 287.82 lakhs), working capital (Rs 130.75 lakhs), and other purposes. SSLL's financial position shows growth in assets, revenue, and net profit based on FY 2025 data.
22Jul 25
Sattva Sukun Lifecare Shareholders Approve Key Resolutions in Extraordinary General Meeting
Sattva Sukun Lifecare Limited held an Extraordinary General Meeting on July 19, 2025, via video conferencing. Shareholders overwhelmingly approved three crucial resolutions: regularization of Mr. Tanmay Paresh Shah as Non-Executive Independent Director, Mr. Gaurav Surendra Nair as Non-Executive Non-Independent Director, and acquisition of 51% or more equity shares in Pavapuri Export Private Limited. The meeting saw participation from 45 members out of 32,581 shareholders. All resolutions received 99.99% votes in favor, with 87,567,632 total votes cast, representing 22.83% of total shareholding.
Industry Peers
MK Exim
Khemani Distributors
Ace Men Engg Works
MRP AgroSattva Sukun Lifecare
Kotia Enterprises
Radhagobind Commercial
64.99
(-1.13%)
113.65
(0.0%)
116.35
(+0.82%)
90.00
(0.0%)
1.12
(+4.67%)
24.17
(0.0%)
1.96
(0.0%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
